Table 3.
Measure | Mean (SEM) | F | p-value |
---|---|---|---|
Total Correct | 0.73 | 0.49 | |
Placebo | 48.3 (1.8) | ||
200 mg Modafinil | 45.4 (3.1) | ||
400 mg Modafinil | 46.6 (3.3) | ||
Total Errors | 0.75 | 0.48 | |
Placebo | 15.6 (1.8) | ||
200 mg Modafinil | 18.6 (3.1) | ||
400 mg Modafinil | 17.4 (3.3) | ||
% Perseverative Responses | 0.91 | 0.41 | |
Placebo | 37.4 (1.8) | ||
200 mg Modafinil | 28.3 (8.8) | ||
400 mg Modafinil | 44.6 (3.6) | ||
% Perseverative Errors | 1.04 | 0.36 | |
Placebo | 35.2 (4.6) | ||
200 mg Modafinil | 27.9 (7.8) | ||
400 mg Modafinil | 45.1 (8.4) | ||
% Nonperseverative Errors | 0.09 | 0.91 | |
Placebo | 50.6 (5.2) | ||
200 mg Modafinil | 50.4 (8.8) | ||
400 mg Modafinil | 54.3 (9.4) | ||
Categories Completed | 0.24 | 0.79 | |
Placebo | 3.5 (0.3) | ||
200 mg Modafinil | 3.3 (0.4) | ||
400 mg Modafinil | 3.6 (0.5) | ||
Trials to Complete 1st Category | 1.95 | 0.15 | |
Placebo | 14.2 (2.3) | ||
200 mg Modafinil | 19.5 (3.8) | ||
400 mg Modafinil | 21.3(4.1) |